- Filed
- Nov 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 12, 2024 | 40.12M sh |
| Long Term Debt | Q3 2024 · Sep 30, 2024 | $4.16M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $4.23M |
| Short Term Debt | Q3 2024 · Sep 30, 2024 | $87K |
| Short Term Debt | Q3 2024 · Dec 31, 2023 | $84K |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $82.32M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $69.72M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $488.74M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $721.63M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $495.83M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $731.09M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $549.92M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $773.85M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $579.16M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $801.8M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $5.74M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2023 | $4.93M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 39.68M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 36.22M sh |
| Capex restated | Q3 2024 · Sep 30, 2023 | $191K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$68.96M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.07 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.24 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.07 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.24 |
| Operating Income | Q3 2024 · Sep 30, 2023 | $4.27M |
| Operating Income | Q3 2024 · Sep 30, 2023 | $13.25M |
| Revenue | Q3 2024 · Sep 30, 2023 | $18.05M |
| Revenue | Q3 2024 · Sep 30, 2023 | $51.81M |